1-10 of 10
Ajita V Singh
Close
Sort by
Journal Articles

A Novel Acanthoic Acid Analog NPI-1342 Blocks IκB Kinase-α and Trigger In Vitro and In Vivo cytotoxicity in Multiple Myeloma Cells

Dharminder Chauhan, PhD, Ajita V. Singh, Arghya Ray, Ph.D, Teru Hideshima, MD, PhD, Paul G. Richardson, MD, Michael A. Palladino, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2011) 118 (21): 1841.
https://doi.org/10.1182/blood.V118.21.1841.1841
Published: 2011
Journal Articles

A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cells

Ajita V. Singh, Madhavi Bandi, Noopur Raje, Paul Richardson, Michael A. Palladino, Dharminder Chauhan, Kenneth C. Anderson
Journal: Blood
Blood (2011) 117 (21): 5692–5700.
https://doi.org/10.1182/blood-2010-12-323857
Published: 2011
Journal Articles

A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma

Dharminder Chauhan, Ajita V. Singh, Monette Aujay, Christopher J. Kirk, Madhavi Bandi, Bryan Ciccarelli, Noopur Raje, Paul Richardson, Kenneth C. Anderson
Journal: Blood
Blood (2010) 116 (23): 4906–4915.
https://doi.org/10.1182/blood-2010-04-276626
Published: 2010
Journal Articles

Anti-Myeloma Activity of Enzymatically Activated Melphalan Prodrug J1

Dharminder Chauhan, PhD, Madhavi Bandi, Ajita V Singh, Klaus Podar, Paul G Richardson, Nikhil C. Munshi, Kristina Viktorsson, Rolf Lewensohn, Jack Spira, Kenneth C. Anderson
Journal: Blood
Blood (2010) 116 (21): 1838.
https://doi.org/10.1182/blood.V116.21.1838.1838
Published: 2010
Journal Articles

A Novel SIRT1 Activator SIRT1720 Triggers In Vitro and In Vivo Cytotoxicity In Multiple Myeloma Via ATM-Dependent Mechanism

Dharminder Chauhan, PhD, Madhavi Bandi, Ajita V Singh, Teru Hideshima, Nikhil C. Munshi, Paul G Richardson, Kenneth C. Anderson
Journal: Blood
Blood (2010) 116 (21): 3007.
https://doi.org/10.1182/blood.V116.21.3007.3007
Published: 2010
Journal Articles

Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma

Dharminder Chauhan, Ajita V. Singh, Bryan Ciccarelli, Paul G. Richardson, Michael A. Palladino, Kenneth C. Anderson
Journal: Blood
Blood (2010) 115 (4): 834–845.
https://doi.org/10.1182/blood-2009-03-213009
Published: 2010
Includes: Supplemental data
Journal Articles

NPI-2358, a Novel Vascular Disrupting Agent Blocks Growth and Angiogenesis in Multiple Myeloma Cells.

Dharminder Chauhan, Ph.D, Ajita V. Singh, Madhavi Bandi, Noopur Raje, M.D., Robert L Schlossman, M.D., G. Kenneth Lloyd, PhD, Paul Richardson, Michael A. Palladino, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 3842.
https://doi.org/10.1182/blood.V114.22.3842.3842
Published: 2009
Journal Articles

PR-924, a Selective Inhibitor of the Immunoproteasome Subunit LMP-7 Blocks Multiple Myeloma Cell Growth Both in Vitro and In Vivo.

Ajita V. Singh, Madhavi Bandi, Monette Aujay, Susan Demo, PhD, Teru Hideshima, Nikhil C. Munshi, Paul G. Richardson, Dharminder Chauhan, Ph.D, Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 612.
https://doi.org/10.1182/blood.V114.22.612.612
Published: 2009
Journal Articles

Combination of a Novel Proteasome Inhibitor NPI-0052 and Lenalidomide Trigger in Vivo Synergistic Cytotoxicity in Multiple Myeloma

Dharminder Chauhan, PhD, Ajita V. Singh, Mohan Brahmandam, Giada Bianchi, Klaus Podar, Teru Hideshima, Nikhil Munshi, Paul Richardson, Michael A. Palladino, PhD, Kenneth C. Anderson
Journal: Blood
Blood (2008) 112 (11): 3662.
https://doi.org/10.1182/blood.V112.11.3662.3662
Published: 2008
Journal Articles

Pharmacodynamic and Efficacy Studies of a Novel Proteasome Inhibitor NPI-0052 in Human Plasmacytoma Xenograft Mouse Model

Ajita V. Singh, G. Kenneth Lloyd, Michael A. Palladino, PhD, Dharminder Chauhan, Kenneth C. Anderson
Journal: Blood
Blood (2008) 112 (11): 3665.
https://doi.org/10.1182/blood.V112.11.3665.3665
Published: 2008